You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | n/a |
| Div Cover | n/a | n/a |
| Op Mrgn | -7,908.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -1.3 | n/a |
| PEG | 0.0 | n/a |
| Price / Revenue | 142.3 | n/a |
| Price / Book value | 3.4 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 212.5% | n/a |
| PBT | 0.0% | n/a |
| EPS | 0.0% | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-08-31 | n/a | -0.17 | -2.85p | -29.8 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 0.00 | -4.80 | -7.87p | -21.0 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | 0.02 | -18.12 | -29.70p | -1.7 | 0.0 | n/a | n/a | 0.0% |
| 2023-12-31 | 0.08 | -7.52 | -11.50p | -10.0 | 0.0 | n/a | n/a | 0.0% |
| Celadon Pharmaceuticals finance chief to step down Sharecast News | 30 Sep |
|---|---|
| Celadon inks partnership with Denmark's Valeos Sharecast News | 11 Sep |
| Celadon confident in seeing through funding challenges Sharecast News | 23 Aug |
| Update on Financial Position | 18-Nov-24 07:01 |
|---|---|
| New Sales Contract with a Healthcare Company | 02-Oct-24 07:01 |
| Departure of Chief Financial Officer | 30-Sep-24 07:06 |
| Interim Results | 30-Sep-24 07:02 |
| Admission of Shares and Total Voting Rights | 17-Sep-24 09:29 |